Marks Lupin's Debut in the Chinese Market MUMBAI, India and BEIJING, May 22, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that China's National Medical Product… For the full story, visit the source.
BusinessMaharashtra
Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension
Marks Lupin's Debut in the Chinese Market MUMBAI, India and BEIJING, May 22, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that China's National Medical Product…
PRNewswire· 5 months ago· 2 min read
This summary is sourced from PRNewswire. Read the full article at:PRNewswire